Cartesian Therapeutics Inc（RNAC）價格預測RNACCartesian Therapeutics Inc

Alphio's RNAC stock price prediction model matches the current Cartesian Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $6.92 (+1.51%). The 1-week path is $6.87 (+0.78%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Cartesian Therapeutics Inc is currently not a strong buy due to its current price of $6.34, which is significantly below its 52-week high of $11.00, indicating potential for recovery but also risk. The RSI is at 40.845, suggesting it is nearing oversold territory, but the forward P/E ratio of 25.0627 indicates high expectations for future earnings that may not be met given recent performance.

Cartesian Therapeutics Inc (RNAC) last closed at $6.8200002, gaining +6.40%. These facts feed the 1-day and 1-week RNAC price prediction above.